Skip Navigation



Carcinogenesis Advance Access published online on January 20, 2005

Carcinogenesis, doi:10.1093/carcin/bgi024
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
26/4/821    most recent
bgi024v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Labrecque, L.
Right arrow Articles by Béliveau, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labrecque, L.
Right arrow Articles by Béliveau, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Oxford University Press
Received October 12, 2004
Revised December 10, 2004
Accepted January 8, 2005

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound*

Lyne Labrecque 1, Sylvie Lamy 1, Amélie Chapus 1, Samira Mihoubi 1, Yves Durocher 2, Brian Cass 2, Michel W. Bojanowski 3, Denis Gingras 1, and Richard Béliveau 1*

1 Laboratoire de Médecine Moléculaire, Hôpital Ste-Justine-Université du Québec à Montréal, Centre de Cancérologie Charles-Bruneau, 3175 Chemin Côte-Ste-Catherine, Montréal, Québec, Canada, H3T1C5
2 Animal Cell Technology Group, Biotechnology Research Institute, National Research Council Canada, 6100 Royalmount Avenue, Montréal, Québec, Canada, H4P2R2
3 Département de Neurochirugie, Hôpital Notre-Dame, 1560 rue Sherbrooke Est Montréal, Québec, Canada H2L4M1

* To whom correspondence should be addressed.
Richard Béliveau, E-mail: molmed{at}justine.umontreal.ca


   Abstract

The vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptors play essential and complementary roles in angiogenesis, and combined inhibition of these receptors has been shown to result in potent antitumor activity in vivo. In this study, we report that ellagic acid, a natural polyphenol found in fruits and nuts, inhibits VEGF-induced phosphorylation of VEGFR-2 in EC as well as PDGF-induced phosphorylation of PDGFR in smooth muscle cells, leading to the inhibition of downstream signaling triggered by these receptors. Ellagic acid also specifically inhibited VEGF-induced migration of endothelial cells as well as their differentiation into capillary-like tubular structures, and abolished PDGF-dependent smooth muscle cell migration. Interestingly, ellagic acid presents a greater selectivity for normal cells than for tumor cells since the migration of the U87 and HT1080 cell lines were much less affected by this molecule. The identification of ellagic acid as a naturally occurring dual inhibitor of VEGF and PDGF receptors suggests that this molecule possesses important antiangiogenic properties that may be helpful for the prevention and treatment of cancer.


* Supported by a grant from the Cancer Research Society to R.B.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
S. Lamy, V. Bedard, D. Labbe, H. Sartelet, C. Barthomeuf, D. Gingras, and R. Beliveau
The Dietary Flavones Apigenin and Luteolin Impair Smooth Muscle Cell Migration and VEGF Expression through Inhibition of PDGFR-{beta} Phosphorylation
Cancer Prevention Research, November 1, 2008; 1(6): 452 - 459.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Lamy, E. Beaulieu, D. Labbe, V. Bedard, A. Moghrabi, S. Barrette, D. Gingras, and R. Beliveau
Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling
Carcinogenesis, May 1, 2008; 29(5): 1033 - 1041.
[Abstract] [Full Text] [PDF]


Home page
cfpHome page
R. Beliveau and D. Gingras
Role of nutrition in preventing cancer
Can Fam Physician, November 1, 2007; 53(11): 1905 - 1911.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Baron-Menguy, A. Bocquet, A.-L. Guihot, D. Chappard, M.-J. Amiot, R. Andriantsitohaina, L. Loufrani, and D. Henrion
Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic
FASEB J, November 1, 2007; 21(13): 3511 - 3521.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Lamy, M. Blanchette, J. Michaud-Levesque, R. Lafleur, Y. Durocher, A. Moghrabi, S. Barrette, D. Gingras, and R. Beliveau
Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation
Carcinogenesis, May 1, 2006; 27(5): 989 - 996.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.